Stoke Therapeutics Inc buy Jefferies Financial Group Inc.
Start price
18.07.25
/
50%
€11.40
Target price
18.07.26
€25.81
Performance (%)
156.14%
Price
10.12.25
€29.20
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ for Stoke Therapeutics Inc has seen massive gains of 156.14%. This prediction currently runs until 18.07.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 9.774% | 9.774% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Jefferies_Financial_ for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $30.00 price target on the stock.
Ratings data for STOK provided by MarketBeat